Skip to main content

Table 7 Adverse events observed among groups B, C and D

From: Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study

Adverse event

Grade 3 or 4, n (%)

p

group B (n = 165)

group C (n = 99)

group D (n = 57)

total (n = 321)

Nausea/Vomiting

26 (15.8)

16 (16.2)

10 (17.5)

52 (16.2)

0.951

Neutropenia

33 (20.0)

19 (19.2)

8 (14.0)

60 (18.7)

0.602

Thrombocytopenia

10 (6.1)

8 (8.1)

3 (5.3)

21 (6.5)

0.985